Stiripentol clinical trials
How each study uses stiripentol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the stiripentol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 20 Aug 2018 · DIACOMIT · NDA 206709 (FDA, Drugs@FDA)
- European Union
- 3 Jan 2007 · Diacomit · EMEA/H/C/000664 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Stiripentol
- 2
Studies by the year they started
5 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2019 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Biocodex (5)
Studies
Open first, then newest update. How each study uses stiripentol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3Not yet recruitingPhase 3BiocodexNCT06465472Written as Stiripentol Oral Capsule
- Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)CompletedPhase 1BiocodexNCT07176832Written as Stiripentol capsule (Diacomit®)
- Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal EpilepsiesCompletedPhase 4BiocodexNCT05419180Written as Stiripentol
- Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary HyperoxaluriaCompletedPhase 2BiocodexNCT03819647Written as stiripentol (Diacomit)
- Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male VolunteersCompletedPhase 1BiocodexNCT03866928Written as Stiripentol
Codes
What other systems call stiripentol · ClinicalTrials.gg INT002736
- MeSH (NLM) C021092stiripentolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) R02XOT8V8ISTIRIPENTOLConfirmed FDA, NLM, Wikidata
- RxNorm 2054968Confirmed FDA, Wikidata
- Wikidata Q412182stiripentolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152433StiripentolOne source FDA
- DrugBank DB09118One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C021092 | stiripentol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | R02XOT8V8I | STIRIPENTOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2054968 | — | Confirmed FDA, Wikidata |
| Wikidata | Q412182 | stiripentol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152433 | Stiripentol | One source FDA |
| DrugBank | DB09118 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.